Global Pharmacovigilance company Apcer today announced the launch of second ‘global services delivery’ centre in Ahmedabad, after New Delhi, aiming to support pharmaceutical companies with ever-changing regulations.
“The delivery centre in Ahmedabad will help life sciences professionals, not just comply but be assured of surpassing drug safety regulations by integrating the latest innovations, technology and digital transformation with ever-changing regulations,” Apcer Chairman Ravi Menon said.
Apcer has five established offices in Princeton, New Jersey, USA; London, England, UK; Hong Kong; New Delhi and Ahmedabad, India it house 700 employees globally.
The move is also focused to expand and upscale its services in India’s healthcare industry involving global pharmaceutical, medical devices, consumer product companies.
“To manage business growth, the expansion in Ahmedabad is vital for our organisation. With our initiative to co-create intellectual properties with technology partners, we are entering into next phase of significant growth and expansion,” Apcer Global Chief Operating Officer and Managing Director, Kunwar Arora said.